Literature DB >> 19957228

Insulinoma.

Kimberly Vanderveen, Clive Grant.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19957228     DOI： 10.1007/978-1-4419-0857-5_13

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  10 in total

1.  [Recurrent hypoglycemia due to an occult insulinoma].

Authors:  T G K Breuer; H L Breuer; B A Menge; A Giese; W Uhl; W E Schmidt; A Tannapfel; D Wild; M A Nauck; J J Meier
Journal:  Internist (Berl)       Date:  2016-04       Impact factor: 0.743

2.  Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys40(AhxHYNIC-[99mTc]/EDDA)NH2]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma.

Authors:  Katra Senica; Ales Tomazic; Ales Skvarca; Petra Kolenc Peitl; Renata Mikolajczak; Alicja Hubalewska-Dydejczyk; Luka Lezaic
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

3.  Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.

Authors:  Olof Eriksson; Irina Velikyan; Ram K Selvaraju; Fouad Kandeel; Lars Johansson; Gunnar Antoni; Barbro Eriksson; Jens Sörensen; Olle Korsgren
Journal:  J Clin Endocrinol Metab       Date:  2014-02-10       Impact factor: 5.958

Review 4.  Pancreatic insulinomas: Laparoscopic management.

Authors:  Pantelis T Antonakis; Hutan Ashrafian; Alberto Martinez-Isla
Journal:  World J Gastrointest Endosc       Date:  2015-11-10

5.  Multifocal Insulinoma in Pancreas and Effect of Intraoperative Ultrasonography.

Authors:  Ersin Borazan; Alper Aytekin; Latif Yilmaz; Muhsin Elci; Mehmet Salih Karaca; Selim Kervancioglu; Ahmet Abdulhalik Balik
Journal:  Case Rep Surg       Date:  2015-07-29

Review 6.  Long-standing insulinoma: two case reports and review of the literature.

Authors:  Mohamed Tarchouli; Abdelmounaim Ait Ali; Moulay Brahim Ratbi; Mohamed said Belhamidi; Mohamed Essarghini; El Mehdi Aboulfeth; Mohamed Bouzroud; Yassir Sbitti; Mohamed Oukabli; Mohammed Elfahssi; Khalid Sair
Journal:  BMC Res Notes       Date:  2015-09-15

7.  ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Authors:  Robert T Jensen; Guillaume Cadiot; Maria L Brandi; Wouter W de Herder; Gregory Kaltsas; Paul Komminoth; Jean-Yves Scoazec; Ramon Salazar; Alain Sauvanet; Reza Kianmanesh
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

8.  Giant insulinoma: report of a case and review of published reports.

Authors:  Kazumitsu Ueda; Tetsuro Taira; Hiroyuki Hakoda; Shoko Nakata; Shinya Okata; Takeshi Nagai; Shigeo Aoki; Hideyuki Mishima; Akihiko Sako; Tsunehiko Maruyama; Minoru Okumura
Journal:  Surg Case Rep       Date:  2016-11-19

9.  A case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus.

Authors:  Emre Bozkirli; Okan Bakiner; Huseyin Abali; Cagatay Andic; Ali Fuat Yapar; Fazilet Kayaselcuk; Eda Ertorer
Journal:  Case Rep Endocrinol       Date:  2013-05-08

10.  JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.

Authors:  Tetsuhide Ito; Toshihiko Masui; Izumi Komoto; Ryuichiro Doi; Robert Y Osamura; Akihiro Sakurai; Masafumi Ikeda; Koji Takano; Hisato Igarashi; Akira Shimatsu; Kazuhiko Nakamura; Yuji Nakamoto; Susumu Hijioka; Koji Morita; Yuichi Ishikawa; Nobuyuki Ohike; Atsuko Kasajima; Ryoji Kushima; Motohiro Kojima; Hironobu Sasano; Satoshi Hirano; Nobumasa Mizuno; Taku Aoki; Takeshi Aoki; Takao Ohtsuka; Tomoyuki Okumura; Yasutoshi Kimura; Atsushi Kudo; Tsuyoshi Konishi; Ippei Matsumoto; Noritoshi Kobayashi; Nao Fujimori; Yoshitaka Honma; Chigusa Morizane; Shinya Uchino; Kiyomi Horiuchi; Masanori Yamasaki; Jun Matsubayashi; Yuichi Sato; Masau Sekiguchi; Shinichi Abe; Takuji Okusaka; Mitsuhiro Kida; Wataru Kimura; Masao Tanaka; Yoshiyuki Majima; Robert T Jensen; Koichi Hirata; Masayuki Imamura; Shinji Uemoto
Journal:  J Gastroenterol       Date:  2021-09-29       Impact factor: 7.527
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.